These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 35637972)

  • 21. Histone acetyltransferase hMOF promotes S phase entry and tumorigenesis in lung cancer.
    Zhao L; Wang DL; Liu Y; Chen S; Sun FL
    Cell Signal; 2013 Aug; 25(8):1689-98. PubMed ID: 23628702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircRNA BIRC6 promotes non-small cell lung cancer cell progression by sponging microRNA-145.
    Yang H; Zhao M; Zhao L; Li P; Duan Y; Li G
    Cell Oncol (Dordr); 2020 Jun; 43(3):477-488. PubMed ID: 32297303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Hbo1-Brd1/Brpf2 complex is responsible for global acetylation of H3K14 and required for fetal liver erythropoiesis.
    Mishima Y; Miyagi S; Saraya A; Negishi M; Endoh M; Endo TA; Toyoda T; Shinga J; Katsumoto T; Chiba T; Yamaguchi N; Kitabayashi I; Koseki H; Iwama A
    Blood; 2011 Sep; 118(9):2443-53. PubMed ID: 21753189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SCF(Fbxw15) mediates histone acetyltransferase binding to origin recognition complex (HBO1) ubiquitin-proteasomal degradation to regulate cell proliferation.
    Zou C; Chen Y; Smith RM; Snavely C; Li J; Coon TA; Chen BB; Zhao Y; Mallampalli RK
    J Biol Chem; 2013 Mar; 288(9):6306-16. PubMed ID: 23319590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histone acetylranseferase hMOF acetylates Nrf2 and regulates anti-drug responses in human non-small cell lung cancer.
    Chen Z; Ye X; Tang N; Shen S; Li Z; Niu X; Lu S; Xu L
    Br J Pharmacol; 2014 Jul; 171(13):3196-211. PubMed ID: 24571482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBO1 HAT complexes target chromatin throughout gene coding regions via multiple PHD finger interactions with histone H3 tail.
    Saksouk N; Avvakumov N; Champagne KS; Hung T; Doyon Y; Cayrou C; Paquet E; Ullah M; Landry AJ; Côté V; Yang XJ; Gozani O; Kutateladze TG; Côté J
    Mol Cell; 2009 Jan; 33(2):257-65. PubMed ID: 19187766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NUP98-HBO1-fusion generates phenotypically and genetically relevant chronic myelomonocytic leukemia pathogenesis.
    Hayashi Y; Harada Y; Kagiyama Y; Nishikawa S; Ding Y; Imagawa J; Shingai N; Kato N; Kitaura J; Hokaiwado S; Maemoto Y; Ito A; Matsui H; Kitabayashi I; Iwama A; Komatsu N; Kitamura T; Harada H
    Blood Adv; 2019 Apr; 3(7):1047-1060. PubMed ID: 30944097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.
    Zhao C; Li Y; Qiu W; He F; Zhang W; Zhao D; Zhang Z; Zhang E; Ma P; Liu Y; Ma L; Yang F; Wang Y; Shu Y
    Oncogene; 2018 Aug; 37(35):4821-4837. PubMed ID: 29773900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HBO1 directs histone H4 specific acetylation, potentiating mechano-transduction pathways and membrane elasticity in ovarian cancer cells.
    Quintela M; Sieglaff DH; Gazze AS; Zhang A; Gonzalez D; Francis L; Webb P; Conlan RS
    Nanomedicine; 2019 Apr; 17():254-265. PubMed ID: 30759370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel histone deacetylase inhibitor exhibits antitumor activity via apoptosis induction, F-actin disruption and gene acetylation in lung cancer.
    Tang YA; Wen WL; Chang JW; Wei TT; Tan YH; Salunke S; Chen CT; Chen CS; Wang YC
    PLoS One; 2010 Sep; 5(9):e12417. PubMed ID: 20856855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HBO1 promotes cell proliferation in bladder cancer via activation of Wnt/β-catenin signaling.
    Chen Z; Zhou L; Wang L; Kazobinka G; Zhang X; Han X; Li B; Hou T
    Mol Carcinog; 2018 Jan; 57(1):12-21. PubMed ID: 28796367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic priming of non-small cell lung cancer cell lines to the antiproliferative and differentiating effects of all-trans retinoic acid.
    Greve G; Schiffmann I; Lübbert M
    J Cancer Res Clin Oncol; 2015 Dec; 141(12):2171-80. PubMed ID: 26008188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 34. Histone acetyltransferase Hbo1: catalytic activity, cellular abundance, and links to primary cancers.
    Iizuka M; Takahashi Y; Mizzen CA; Cook RG; Fujita M; Allis CD; Frierson HF; Fukusato T; Smith MM
    Gene; 2009 May; 436(1-2):108-14. PubMed ID: 19393168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The histone acetyltransferase HBO1 promotes efficient tip cell sprouting during angiogenesis.
    Grant ZL; Hickey PF; Abeysekera W; Whitehead L; Lewis SM; Symons RCA; Baldwin TM; Amann-Zalcenstein D; Garnham AL; Naik SH; Smyth GK; Thomas T; Voss AK; Coultas L
    Development; 2021 Oct; 148(20):. PubMed ID: 34550360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Romidepsin induces cell cycle arrest, apoptosis, histone hyperacetylation and reduces matrix metalloproteinases 2 and 9 expression in bortezomib sensitized non-small cell lung cancer cells.
    Karthik S; Sankar R; Varunkumar K; Ravikumar V
    Biomed Pharmacother; 2014 Apr; 68(3):327-34. PubMed ID: 24485799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long Non-Coding RNA THOR Depletion Inhibits Human Non-Small Cell Lung Cancer Cell Growth.
    Jiao PF; Tang PJ; Chu D; Li YM; Xu WH; Ren GF
    Front Oncol; 2021; 11():756148. PubMed ID: 34868966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer.
    Fang T; Huang H; Li X; Liao J; Yang Z; Hoffman RM; Cheng XI; Liang L; Hu W; Yun S
    Anticancer Res; 2018 Jan; 38(1):179-186. PubMed ID: 29277771
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.
    Bouillez A; Rajabi H; Pitroda S; Jin C; Alam M; Kharbanda A; Tagde A; Wong KK; Kufe D
    Cancer Res; 2016 Mar; 76(6):1538-48. PubMed ID: 26833129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulated
    Sui J; Zhao Q; Zhang Y; Liang G
    DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.